Denali Therapeutics saw the highest growth of 82% in patent filings in February and 149% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 54% and grants by 41%. GlobalData’s DataBook provides a comprehensive analysis of Denali Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Denali Therapeutics has been focused on protecting inventions in United States(US) with eight publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 33% filings and 30% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Israel(IL) patent Office are among the top ten patent offices where Denali Therapeutics is filings its patents. Among the top granted patent authorities, Denali Therapeutics has 30% of its grants in United States(US), 30% in Israel(IL) and 20% in European Patent Office(EPO).

F. Hoffmann-La Roche could be the strongest competitor for Denali Therapeutics

Patents related to rare diseases lead Denali Therapeutics's portfolio

Denali Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q1 2024.

Parkinson's disease related patents lead Denali Therapeutics portfolio followed by alzheimer's disease, and amyotrophic lateral sclerosis

Denali Therapeutics has highest number of patents in parkinson's disease followed by alzheimer's disease, amyotrophic lateral sclerosis, mucopolysaccharidosis iii (mps iii) (sanfilippo syndrome ), and frontotemporal dementia with parkinsonism-17 (ftdp-17). For parkinson's disease, nearly 9% of patents were filed and 22% of patents were granted in Q1 2024.

For comprehensive analysis of Denali Therapeutics's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.